Emily Bodnar
Stock Analyst at HC Wainwright & Co.
(1.83)
# 3,291
Out of 5,147 analysts
352
Total ratings
28.48%
Success rate
-7.74%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Emily Bodnar
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NVCR NovoCure | Maintains: Buy | $47 → $49 | $13.67 | +258.45% | 22 | Feb 26, 2026 | |
| ACLX Arcellx | Downgrades: Neutral | $115 | $113.79 | +1.06% | 15 | Feb 23, 2026 | |
| AUTL Autolus Therapeutics | Initiates: Buy | $9 | $1.71 | +426.32% | 1 | Feb 17, 2026 | |
| AGIO Agios Pharmaceuticals | Maintains: Buy | $62 → $65 | $30.23 | +115.02% | 5 | Feb 12, 2026 | |
| RAPT RAPT Therapeutics | Downgrades: Neutral | $58 | $57.98 | +0.03% | 4 | Jan 20, 2026 | |
| VTYX Ventyx Biosciences | Downgrades: Neutral | $14 | $13.97 | +0.21% | 17 | Jan 8, 2026 | |
| VTVT vTv Therapeutics | Maintains: Buy | $36 → $47 | $38.16 | +23.17% | 3 | Dec 19, 2025 | |
| RCUS Arcus Biosciences | Maintains: Buy | $28 → $32 | $20.37 | +57.09% | 7 | Dec 12, 2025 | |
| OLMA Olema Pharmaceuticals | Maintains: Buy | $36 → $45 | $24.20 | +85.95% | 23 | Dec 11, 2025 | |
| ACRV Acrivon Therapeutics | Reiterates: Buy | $19 | $1.51 | +1,158.28% | 13 | Nov 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $52 → $51 | $55.05 | -7.36% | 13 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $15 | $5.82 | +157.73% | 2 | Nov 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $9 | $4.21 | +113.78% | 12 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $5 | $2.25 | +122.22% | 13 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $0.94 | +1,171.32% | 1 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $60 | $30.09 | +99.40% | 1 | Oct 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.35 | - | 14 | Sep 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 | $3.33 | +590.69% | 20 | Sep 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $40 | $3.82 | +947.12% | 15 | Aug 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $35 | $10.95 | +219.63% | 14 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $8 | $0.57 | +1,303.76% | 25 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $9 | $4.10 | +119.51% | 2 | Jul 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $20 | $1.38 | +1,349.28% | 10 | Jul 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $36 | $12.72 | +183.02% | 9 | Jul 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $560 → $280 | $9.61 | +2,813.63% | 17 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $2.47 | +223.89% | 6 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $2.98 | +906.71% | 7 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18 | $2.70 | +566.67% | 15 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $183 | $3.25 | +5,518.77% | 12 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $35 | $4.43 | +690.07% | 14 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $1.68 | - | 5 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $33 | $0.44 | +7,359.31% | 14 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $2.82 | - | 1 | Apr 25, 2024 |
NovoCure
Feb 26, 2026
Maintains: Buy
Price Target: $47 → $49
Current: $13.67
Upside: +258.45%
Arcellx
Feb 23, 2026
Downgrades: Neutral
Price Target: $115
Current: $113.79
Upside: +1.06%
Autolus Therapeutics
Feb 17, 2026
Initiates: Buy
Price Target: $9
Current: $1.71
Upside: +426.32%
Agios Pharmaceuticals
Feb 12, 2026
Maintains: Buy
Price Target: $62 → $65
Current: $30.23
Upside: +115.02%
RAPT Therapeutics
Jan 20, 2026
Downgrades: Neutral
Price Target: $58
Current: $57.98
Upside: +0.03%
Ventyx Biosciences
Jan 8, 2026
Downgrades: Neutral
Price Target: $14
Current: $13.97
Upside: +0.21%
vTv Therapeutics
Dec 19, 2025
Maintains: Buy
Price Target: $36 → $47
Current: $38.16
Upside: +23.17%
Arcus Biosciences
Dec 12, 2025
Maintains: Buy
Price Target: $28 → $32
Current: $20.37
Upside: +57.09%
Olema Pharmaceuticals
Dec 11, 2025
Maintains: Buy
Price Target: $36 → $45
Current: $24.20
Upside: +85.95%
Acrivon Therapeutics
Nov 25, 2025
Reiterates: Buy
Price Target: $19
Current: $1.51
Upside: +1,158.28%
Nov 24, 2025
Maintains: Buy
Price Target: $52 → $51
Current: $55.05
Upside: -7.36%
Nov 12, 2025
Maintains: Buy
Price Target: $12 → $15
Current: $5.82
Upside: +157.73%
Nov 7, 2025
Maintains: Buy
Price Target: $11 → $9
Current: $4.21
Upside: +113.78%
Nov 6, 2025
Maintains: Buy
Price Target: $4 → $5
Current: $2.25
Upside: +122.22%
Oct 14, 2025
Initiates: Buy
Price Target: $12
Current: $0.94
Upside: +1,171.32%
Oct 6, 2025
Assumes: Buy
Price Target: $60
Current: $30.09
Upside: +99.40%
Sep 29, 2025
Downgrades: Neutral
Price Target: n/a
Current: $0.35
Upside: -
Sep 10, 2025
Reiterates: Buy
Price Target: $23
Current: $3.33
Upside: +590.69%
Aug 27, 2025
Maintains: Buy
Price Target: $32 → $40
Current: $3.82
Upside: +947.12%
Aug 15, 2025
Upgrades: Buy
Price Target: $35
Current: $10.95
Upside: +219.63%
Aug 11, 2025
Maintains: Buy
Price Target: $12 → $8
Current: $0.57
Upside: +1,303.76%
Jul 22, 2025
Maintains: Buy
Price Target: $10 → $9
Current: $4.10
Upside: +119.51%
Jul 7, 2025
Maintains: Buy
Price Target: $40 → $20
Current: $1.38
Upside: +1,349.28%
Jul 1, 2025
Reiterates: Buy
Price Target: $36
Current: $12.72
Upside: +183.02%
Apr 16, 2025
Maintains: Buy
Price Target: $560 → $280
Current: $9.61
Upside: +2,813.63%
Apr 1, 2025
Reiterates: Buy
Price Target: $8
Current: $2.47
Upside: +223.89%
Mar 31, 2025
Reiterates: Buy
Price Target: $30
Current: $2.98
Upside: +906.71%
Mar 27, 2025
Reiterates: Buy
Price Target: $18
Current: $2.70
Upside: +566.67%
Mar 26, 2025
Reiterates: Buy
Price Target: $183
Current: $3.25
Upside: +5,518.77%
Mar 26, 2025
Reiterates: Buy
Price Target: $35
Current: $4.43
Upside: +690.07%
Mar 12, 2025
Reiterates: Neutral
Price Target: n/a
Current: $1.68
Upside: -
Nov 15, 2024
Reiterates: Buy
Price Target: $33
Current: $0.44
Upside: +7,359.31%
Apr 25, 2024
Reiterates: Neutral
Price Target: n/a
Current: $2.82
Upside: -